LILRB2 and neoplasm: Another study also showed intratumoral heterogeneity in ccRCC patients (108) with very heterogeneous staining pattern for HLA-G ranging between 37 – 70% of HLA-G throughout one tumor using IHC as well as for ILT4, which preferentially binds HLA-G.